CORONAVIRUS: DIAGNÓSTICO Y TERAPIA EN HUMANOS

VolverVolver

Resultados 389 resultados LastUpdate Última actualización 30/09/2022 [14:06:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días/Published applications in the last 60 days



Página1 de 16 nextPage   por página


METHOD FOR THE TREATMENT OF COVID-19 INFECTIONS WITH PALMITOYLETHANOLAMIDE

NºPublicación: US2022304956A1 29/09/2022

Solicitante:

EPITECH GROUP S P A [IT]

Resumen de: US2022304956A1

The present invention relates to a method of treating a COVID-19 infection by administering an effective amount of an endogenous compound devoid of significant toxicity. In particular, the present invention relates to a method of treating a patient affected by COVID-19 infection comprising administering an effective amount of a mixture of ultra-micronized palmitoylethanolamide and micronized palmitoylethanolamide to said patient.

traducir

TREATMENT OF LONG HAULERS SYNDROME WITH NICLOSAMIDE

NºPublicación: US2022304959A1 29/09/2022

Solicitante:

FIRST WAVE BIOPHARMA [US]

Resumen de: US2022304959A1

Disclosed in certain embodiments is a method of treating long-haulers syndrome associated with infection (e.g., Covid-19) comprising administering a therapeutically effective amount of niclosamide or a pharmaceutically acceptable salt thereof to a patient in need thereof.

traducir

METHOD FOR THE TREATMENT OF COVID-19 INFECTIONS WITH PALMITOYLETHANOLAMIDE

NºPublicación: US2022304954A1 29/09/2022

Solicitante:

EPITECH GROUP S P A [IT]

Resumen de: US2022304954A1

The present invention relates to a method of treating a COVID-19 infection by administering an effective amount of an endogenous compound devoid of significant toxicity. In particular, the present invention relates to a method of treating a patient affected by COVID-19 infection comprising administering an effective amount of a mixture of ultra-micronized palmitoylethanolamide and micronized palmitoylethanolamide to said patient.

traducir

COMPOSITIONS AND METHODS FOR DIAGNOSING VIRAL INFECTIONS INCLUDING COVID-19 AND FOR INFECTION SEVERITY MONITORING AS WELL AS TARGETED DETECTION OF CYTOKINE STORM

NºPublicación: US2022305145A1 29/09/2022

Solicitante:

VYRIPHARM ENTPR INC [US]

Resumen de: US2022305145A1

Compositions and methods for the diagnosis and treatment of infectious diseases, including for the diagnosis and treatment of Cytokine Storm and Cytokine Release Syndrome. The compositions may include a conjugate of a nucleoside analog, a chelator, and a label for use as imaging and therapeutic agents.

traducir

COMPOSITIONS AND METHODS FOR INHIBITING PROTEOLYTIC ACTIVATION OF VIRUSES

NºPublicación: US2022304947A1 29/09/2022

Solicitante:

MAJEED MUHAMMED [IN]
NAGABHUSHANAM KALYANAM [US]
MUNDKUR LAKSHMI [IN]

Resumen de: US2022304947A1

The present invention discloses use of a composition comprising enriched in bisdemethoxycurcumin, specifically a composition comprising not less than 20% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin and 10-50% curcumin in preventing the activation of viral spike proteins by inhibiting the activity of proteolytic enzymes and in inhibiting the replication and growth of pathogenic viruses, specifically SARS-CoV-2 in mammalian cells. The invention also discloses the potential of the above composition in managing SARS-CoV-2 induced infections.

traducir

MASSIVELY PARALLEL COVID-19 DIAGNOSTIC ASSAY FOR SIMULTANEOUS TESTING OF 19200 PATIENT SAMPLES

NºPublicación: US2022307095A1 29/09/2022

Solicitante:

PENN STATE RES FOUND [US]

Resumen de: US2022307095A1

The present disclosure provides methods and systems for the massively-parallel detection of pathogens, such as SARS-CoV-2 virus, in a set of multiple samples via PCR test. Various implementations may provide for barcode/primer sequences that are designed to allow for a large number of samples and/or multiple pathogens to be analyzed in a single test. Included within the scope hereof are methods and systems for performing tests of multiple samples at once, via a one-pot test protocol, as well as methods and systems for designing test parameters (such as barcode/primer sequences) in a manner that allows for parallel testing.

traducir

KIT FOR DETECTING NOVEL CORONAVIRUS, AND PREPARATION METHOD THEREFOR AND DETECTION METHOD THEREFOR

NºPublicación: EP4063865A1 28/09/2022

Solicitante:

BEIJING JINWOFU BIOENGINEERING TECH CO LTD [CN]

Resumen de: EP4063865A1

The present discosure discloses a detection kit and a preparation method thereof and a detection method for novel coronavirus, and relates to the technical field of biomedicine, including antigen test strip; the antigen test strip includes a substrate, bibulous paper, immune nitrocellulose membrane, and immune microsphere pad; the immune microsphere pad, the immune nitrocellulose membrane and the bibulous paper are pasted on the substrate; the immune microsphere pad is coated with latex microsphere-labeled novel coronavirus SARS-CoV-2 monoclonal antibody 1; immune nitrocellulose membrane is provided with a test line coated with novel coronavirus SARS-CoV-2 monoclonal antibody 2 and a quality control line coated with goat anti-mouse IgG polyclonal antibody. The present disclosure uses latex particles as labeled tracer, and uses antigen-antibody reaction and lateral chromatography to detect and analyze targets, having advantages of convenience and swift, and is convenient to be widely carried out in grass-roots community hospitals and health service centers.

traducir

COMPOSITION, KIT, METHOD FOR DETECTING SARS-COV-2 AND USE THEREOF

NºPublicación: EP4063523A1 28/09/2022

Solicitante:

SANSURE BIOTECH INC [CN]

WO_2021243921_A1

Resumen de: EP4063523A1

A composition for detecting SARS-CoV-2 is provided; moreover, a kit including the composition, the use of the kit, and a method for detecting SARS-CoV-2 are also provided.

traducir

HUMAN NEUTRALIZING ANTIGEN SPECIFIC PROTEINS FOR SPIKE-RBD OF SARS-COV-2

NºPublicación: EP4063384A1 28/09/2022

Solicitante:

CEINGE BIOTECNOLOGIE AVANZATE SCARL [IT]

Resumen de: EP4063384A1

The invention concerns antigen specific proteins, in particular antibodies of fragments thereof, specifically binding to RBD domain and interfering in the interaction of Spike protein with ACE2 receptor, said antigen specific proteins having neutralizing activity for SARS-CoV2 virus infection.

traducir

METHODS AND DEVICES DETECTING SARS-COV-2

NºPublicación: EP4061962A1 28/09/2022

Solicitante:

SARMAL INC [US]

CA_3159007_PA

Resumen de: WO2021102210A1

Provided herein are methods, systems and devices for detecting a nucleic acid sequences and/or pathogens; including detecting the presence of absence of a target-nucleic acid sequences, including SARS-COV2.

traducir

NEW APPLICATION OF AN IMMUNOGENIC OR VACCINE COMPOSITION AGAINST COVID-19

NºPublicación: EP4062930A1 28/09/2022

Solicitante:

EYE VACC [BE]

DE_102021001467_PA

Resumen de: EP4062930A1

La présente invention concerne une composition immunogène ou vaccinale contre le SARS-CoV-2, pour son utilisation dans le traitement de la Covid-19, caractérisée en ce qu'elle est administrée sur la muqueuse oculaire et/ou la muqueuse uro-génitale.

traducir

USE OF PALMITOYLETHANOLAMIDE FOR THE PREVENTION AND/OR TREATMENT OF COVID-19 INFECTIONS

NºPublicación: CA3148037A1 26/09/2022

Solicitante:

EPITECH GROUP S P A [IT]

Resumen de: CA3148037A1

The present invention relates to a method of treating a COVID-19 infection by administering an effective amount of an endogenous compound devoid of significant toxicity. In particular, the present invention relates to a method of treating a patient affected by COVID-19 infection comprising administering an effective amount of a mixture of ultra-micronized palmitoylethanolamide and micronized palmitoylethanolamide to said patient.

traducir

Pharmaceutical use of ketoamide-based compound

NºPublicación: AU2021213137A1 22/09/2022

Solicitante:

SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES

TW_202130628_A

Resumen de: AU2021213137A1

Use of a class of ketoamide-based compounds, in particular, use of the ketoamide-based compound as represented by general formula A as a 2019 novel coronavirus (2019-nCov) 3CL protease inhibitor and/or human cathepsin L inhibitor in preparation of a medicament for treating and/or preventing and relieving respiratory tract infection, pneumonia and other related diseases caused by 2019 novel coronavirus infection. The present invention also relates to use of pharmaceutical compositions of the class of compounds, pharmaceutical salts, enantiomeric forms, diastereoisomers and racemic compounds thereof in preparation of a medicament for treating and/or preventing and relieving respiratory tract infections and other related diseases caused by the 2019 novel coronavirus infection.

traducir

RECOMBINANT SARS-CoV-2 IMMUNOGENIC PROTEIN PRODUCED IN PLANTS AND THE USE THEREOF

NºPublicación: WO2022197255A1 22/09/2022

Solicitante:

BAIYA PHYTOPHARM CO LTD [TH]

Resumen de: WO2022197255A1

The present invention demonstrates a recombinant vector for producing immunogenic substance from plants which can induce an immune response in mammals against the coronavirus disease 2019 (COVID-19). Said recombinant vector comprises at least a fragment of SARS Co V-2 receptor binding domain protein ( SARS Co V-2 RBD) and a fusion protein sequence. The recombinant vector is introduced into plant cells, preferrably by means of Agrobacterium sp., thereby the plant cell can express a recombinant protein which can act as an immunogenic substance. The recombinant protein of the present invention s igruficantly demonstrates an ability to trigger immunogenicity in mammals which prevents infectious disease caused by severe acute respirato1y syndrome coronavirus 2. Further, the method of inducing an immune response against SARS- Co V- 2 in mammals is also provided herein. The present invention further demonstrates the use of such recombinant protein as a vaccine to prevent the coronavirus disease 201 9 (COVID-1 9).

traducir

ROOM TEMPERATURE STABLE, SINGLE SHOT mRNA VACCINE FOR COVID-19

NºPublicación: US2022296728A1 22/09/2022

Solicitante:

CASTOR TREVOR PERCIVAL [US]

Resumen de: US2022296728A1

This disclosed technology relates to a new mRNA COVID-19 vaccine that is stable at room temperature, requires only one injection, and is less prone to patient hypersensitivity reactions. The vaccine is practical to deploy globally during vaccination campaigns for current and future coronavirus pandemics and other infectious diseases. The disclosed technology is a method and system for producing the vaccine, and also a double-encapsulated mRNA vaccine product. The method uses double nanoencapsulation of an mRNA vaccine, first in phospholipid nanosomes and then in biodegradable polymer nanospheres. The method may be carried out as a continuous flow, integral, or two-stage processes. The method and system use supercritical fluid technology for nanoencapsulating mRNA in a solvent free process that minimizes loss of potency and preserves antigenicity of the nanoencapsulated mRNA and eliminates residual organic solvents in the final product. The double-encapsulated mRNA vaccine product is stable at room temperature and can be administered in a single shot to humans.

traducir

SYNTHETIC PLASMID DNA VACCINE EXPRESSING A CODON-OPTIMIZED SARS-COV-2 SPIKE PROTEIN AND METHODS FOR ITS USE

NºPublicación: US2022296700A1 22/09/2022

Solicitante:

KING ABDULAZIZ UNIVERISTY [SA]

US_2022296701_PA

Resumen de: US2022296700A1

A synthetic DNA vaccine against SARS-CoV-2 infection comprises a codon-optimized coding sequence for optimal mammalian expression of a pSARS2 spike glycoprotein (pSARS2-S). The signal peptide may be replaced with the signal peptide from the human IgG2 heavy chain. Systemic S1-specific IgG antibodies and neutralizing antibodies (nAbs) were significantly induced in mice at 2 weeks-post three injections with 100 μg of the pSARS2-S vaccine via intramuscular (IM) needle injection. IM immunization induced Th1-skewed and long-lasting IgG response in BALB/c mice. Immunogenicity and induction of nAbs were enhanced with a needle-free delivery system, wherein two doses were sufficient to elicit significant levels of systemic S1-specific IgG antibodies and nAbs via IM or intradermal immunization.

traducir

TREATMENT OR PREVENTION OF CORONAVIRIDAE INFECTION

NºPublicación: US2022296676A1 22/09/2022

Solicitante:

WATERSTONE PHARMACEUTICALS WUHAN CO LTD [CN]

JP_2022539640_PA

Resumen de: US2022296676A1

A method of treating or preventing a Coronaviridae infection in a subject comprising administrating a therapeutically effective amount of a compound of Formula I or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the Coronaviridae comprises at least one selected from 2019-nCov virus, HCov 229E virus, SARS virus, MERS virus,

traducir

RAPID DIAGNOSTIC TEST COMPONENT

NºPublicación: US2022299508A1 22/09/2022

Solicitante:

DETECT INC [US]

WO_2022197635_PA

Resumen de: US2022299508A1

Provided herein, in some embodiments, are rapid diagnostic tests to detect one or more target nucleic acid sequences (e.g., a nucleic acid sequence of one or more pathogens). In some embodiments, the pathogens are viral, bacterial, fungal, parasitic, or protozoan pathogens, such as SARS-CoV-2 or an influenza virus. Further embodiments provide methods of detecting genetic abnormalities. Diagnostic tests comprising a sample-collecting component, one or more reagents (e.g., lysis reagents, nucleic acid amplification reagents), and a detection component (e.g., a component comprising a lateral flow assay strip) are provided.

traducir

OPTICAL COVID-19 DETECTION SYSTEM

NºPublicación: US2022299506A1 22/09/2022

Solicitante:

UNIV ILLINOIS [US]

WO_2022197853_A1

Resumen de: US2022299506A1

The disclosure provides example devices and methods for making and using the devices for rapid testing for the SARS-CoV-2 virus. The example device includes (a) a substrate coupled to a metal oxide layer, (b) a graphene layer coupled to the metal oxide layer, (c) a chemical or biochemical linker functionalized with the graphene layer, and (d) a plurality of SARS-CoV-2 receptors that are bound to the graphene layer via the chemical or biochemical linker, wherein the plurality of SARS-CoV-2 receptors comprise SARS-CoV-2 spike antibodies or SARS-CoV-2 spike proteins, where the graphene layer is configured to have a first phononic energy, when the plurality of SARS-CoV-2 receptors are unattached to target molecules, and a second phononic energy, when the plurality of SARS-CoV-2 receptors are attached to target molecules.

traducir

TREATMENT FOR DISEASES CORRELATED WITH PANNEXIN 1 EXPRESSION

NºPublicación: WO2022197869A2 22/09/2022

Solicitante:

AMERIMMUNE LLC [US]
ALPAN ORAL [US]

Resumen de: WO2022197869A2

Up-regulation of caspase has been found in COVID-19 patients, and also occurs in patients suffering from diabetes, hypertension, metabolic syndrome, and other conditions. Such up-regulation can be responsible for poor clinical outcomes in patients having such diseases or disorders, as such up-regulation leads to a process called pyroptosis: death and malfunction of immune system cells, particularly of certain types of lymphocytes. An inhibitor of caspase such as a caspase 1 inhibitor, or "pan-caspase" inhibitor (i.e., an inhibitor of multiple caspase types including caspase-1), can be used to treat COVID-19 patients or individuals at risk of infection, by limiting the malfunction of the immune system. A caspase-1 or pan-caspase inhibitor is advantageously administered before or very early in the course of infection by a positive-sense, single-stranded RNA virus such as SARS-CoV, MERS-CoV, and SARS-Cov-2.

traducir

FOLLICULAR HELPER T (TFH) CELLS SPECIFIC TO SARS-COV-2 VIRUS

NºPublicación: WO2022196699A1 22/09/2022

Solicitante:

UNIV OSAKA [JP]
KOTAI BIOTECHNOLOGIES INC [JP]

Resumen de: WO2022196699A1

Provided are follicular helper T cells specific to SARS-CoV-2 virus. On the basis of the discovery of a public Tfh TCR that is specific to a spike (S) protein common to various patients, the present disclosure identifies for the first time a SARS-CoV-2 virus-specific public TCR and the MHC and antigenic epitope thereof and thus promotes efficient immune responses, especially the response of B cells producing a neutralizing antibody. The present disclosure provides, for example, a SARS-CoV-2 virus-specific epitope-containing composition for inducing follicular T cells.

traducir

DETECTION DEVICE

NºPublicación: WO2022194296A1 22/09/2022

Solicitante:

ACON BIOTECH HANGZHOU CO LTD [CN]

CN_215575177_U

Resumen de: WO2022194296A1

Provided in the present invention is a detection device, which comprises a supporting plate, wherein a sample treatment pad, a reaction membrane and a water absorption pad are sequentially overlapped and adhered to the supporting plate from upstream to downstream, and a hydrophobic element is arranged at the downstream end of the water absorption pad of the detection device. The hydrophobic element, as a gripping area, can prevent further flow of a sample solution on the water absorption pad to an area, which is gripped by a user, of the detection device. The detection device of the present invention can effectively reduce the risk of infection of a user during sample inspection, especially the risk of infection of the user during sample inspection of infectious diseases, such as HBV, HIV, malaria, dengue fever, SARS and SARS-CoV-2.

traducir

RECOMBINANT MEASLES VIRUS

NºPublicación: WO2022195900A1 22/09/2022

Solicitante:

UNIV TOKYO [JP]

Resumen de: WO2022195900A1

The present invention provides: a recombinant measles virus useful as a live vaccine against COVID-19; and a vector used for producing the recombinant measles virus. That is, the present invention is a recombinant measles virus in which a gene encoding a protein of corona virus SARS-CoV-2 is inserted between the N gene region and the P gene region in a measles virus gene; the recombinant measles virus in which the protein is the spike protein of SARS-CoV-2 or a partial protein thereof; and DNA in which a gene encoding a protein of SARS-CoV-2 is inserted into the region from the base at position 1686 to the base at position 1694 in the nucleotide sequence represented by SEQ ID NO: 2.

traducir

TEST COMBINATION PACKET AND TEST METHOD

NºPublicación: WO2022194286A1 22/09/2022

Solicitante:

ACON BIOTECH HANGZHOU CO LTD [CN]

CN_115112640_A

Resumen de: WO2022194286A1

The present invention provides a test combination packet and a test method for rapid sample test and analysis. The test combination packet comprises a test board and a sample extraction tube. The test combination packet and the test method provided by the present invention can improve the sensitivity of a product, play a positive role in suppressing the propagation of pathogens that cause respiratory diseases, and are suitable for rapid test of antigens and antibodies such as the currently popular novel coronavirus.

traducir

DIPHENYL ALKANE COMPOUND AND PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

Nº publicación: WO2022194136A1 22/09/2022

Solicitante:

INST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCICENCES [CN]

Resumen de: WO2022194136A1

The invention belongs to the technical field of medicine. A soluble berberine-type quaternary ammonium alkaloid compound and the use thereof in preparing a drug are disclosed. In particular, disclosed are a compound as represented by general formula A and a compound that further may be represented specifically by general formulas I and I', a pharmaceutical composition thereof, a preparation method therefor, and the use thereof. The compounds of the present invention have significant activity in treating cardiovascular, cerebrovascular and blood system diseases, inflammatory diseases, febrile diseases, tumor diseases, autoimmune diseases and viral infectious diseases and complications thereof by inhibiting/reducing the activity of biological body pathological NO, iNOS, IL-6 and autoantibody levels, and inhibiting the activity of SARS-COV 2 virus RNA replication. The strength of the physical and chemical properties as well as the pharmacological function of the compounds of the present invention are superior to those of control drugs and related compounds, and can be used for preparing drugs for preventing, alleviating and/or treating cardiovascular, cerebrovascular and blood system diseases, inflammatory diseases, febrile diseases, tumor diseases, autoimmune diseases and viral infection diseases and complications thereof.

traducir

Página1 de 16 nextPage por página

punteroimgVolver